Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review.
Jacobsen LM, Sherr JL, Considine E, Chen A, Peeling SM, Hulsmans M, Charleer S, Urazbayeva M, Tosur M, Alamarie S, Redondo MJ, Hood KK, Gottlieb PA, Gillard P, Wong JJ, Hirsch IB, Pratley RE, Laffel LM, Mathieu C; ADA/EASD PMDI. Jacobsen LM, et al. Among authors: sherr jl. Commun Med (Lond). 2023 Oct 5;3(1):132. doi: 10.1038/s43856-023-00358-x. Commun Med (Lond). 2023. PMID: 37794113 Free PMC article.
Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes (VibRate): A multinational prospective observational real-world cohort study.
Dovc K, Van Name M, Jenko Bizjan B, Rusak E, Piona C, Yesiltepe-Mutlu G, Mentink R, Frontino G, Macedoni M, Ferreira SH, Serra-Caetano J, Galhardo J, Pelicand J, Silvestri F, Sherr J, Chobot A, Biester T; ISPAD JENIOUS Group. Dovc K, et al. Diabetes Obes Metab. 2022 Mar;24(3):564-569. doi: 10.1111/dom.14607. Epub 2021 Dec 27. Diabetes Obes Metab. 2022. PMID: 34820985 Free PMC article. No abstract available.
Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial.
Herold KC, Gitelman SE, Willi SM, Gottlieb PA, Waldron-Lynch F, Devine L, Sherr J, Rosenthal SM, Adi S, Jalaludin MY, Michels AW, Dziura J, Bluestone JA. Herold KC, et al. Diabetologia. 2013 Feb;56(2):391-400. doi: 10.1007/s00125-012-2753-4. Epub 2012 Oct 21. Diabetologia. 2013. PMID: 23086558 Free PMC article. Clinical Trial.
Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.
Shah VN, Bailey R, Wu M, Foster NC, Pop-Busui R, Katz M, Crandall J, Bacha F, Nadeau K, Libman I, Hiers P, Mizokami-Stout K, DiMeglio LA, Sherr J, Pratley R, Agarwal S, Snell-Bergeon J, Cengiz E, Polsky S, Mehta SN. Shah VN, et al. J Clin Endocrinol Metab. 2020 May 1;105(5):e2032-8. doi: 10.1210/clinem/dgaa015. J Clin Endocrinol Metab. 2020. PMID: 31955209 Free PMC article.
Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Laffel LM, Kanapka LG, Beck RW, Bergamo K, Clements MA, Criego A, DeSalvo DJ, Goland R, Hood K, Liljenquist D, Messer LH, Monzavi R, Mouse TJ, Prahalad P, Sherr J, Simmons JH, Wadwa RP, Weinstock RS, Willi SM, Miller KM; CGM Intervention in Teens and Young Adults with T1D (CITY) Study Group; CDE10. Laffel LM, et al. JAMA. 2020 Jun 16;323(23):2388-2396. doi: 10.1001/jama.2020.6940. JAMA. 2020. PMID: 32543683 Free PMC article. Clinical Trial.
Prevention of type 1 diabetes: the time has come.
Sherr J, Sosenko J, Skyler JS, Herold KC. Sherr J, et al. Nat Clin Pract Endocrinol Metab. 2008 Jun;4(6):334-43. doi: 10.1038/ncpendmet0832. Epub 2008 Apr 29. Nat Clin Pract Endocrinol Metab. 2008. PMID: 18446141 Review.
137 results